Grandeur Peak Global Advisors, LLC - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 129 filers reported holding ARATANA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
Grandeur Peak Global Advisors, LLC ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$3,927,000
-22.0%
1,090,868
+32.9%
0.44%
-31.1%
Q4 2018$5,033,000
+0.9%
821,038
-3.8%
0.65%
+24.5%
Q3 2018$4,987,000
+64.8%
853,888
+19.9%
0.52%
+67.4%
Q2 2018$3,027,000
+24.7%
712,138
+29.4%
0.31%
+13.1%
Q1 2018$2,428,000
-14.3%
550,463
+2.2%
0.27%
-25.5%
Q4 2017$2,832,000
-14.2%
538,3630.0%0.37%
-27.0%
Q3 2017$3,300,000
-15.2%
538,3630.0%0.50%
-10.3%
Q2 2017$3,892,000
+91.5%
538,363
+40.4%
0.56%
+69.3%
Q1 2017$2,032,000
-20.5%
383,363
+7.6%
0.33%
-29.2%
Q4 2016$2,557,000
-30.7%
356,138
-9.7%
0.47%
-34.8%
Q3 2016$3,692,000
-48.5%
394,450
-67.5%
0.72%
-3.5%
Q2 2016$7,171,000
+109.3%
1,213,200
+95.4%
0.74%
+8.6%
Q1 2016$3,427,000
+33.3%
620,850
+34.8%
0.69%
+29.4%
Q4 2015$2,571,000
+1386.1%
460,675
+2152.7%
0.53%
+1259.0%
Q3 2015$173,000
-82.7%
20,450
-69.1%
0.04%
-80.2%
Q2 2015$999,000
-5.6%
66,1000.0%0.20%
-12.1%
Q1 2015$1,058,000
-67.0%
66,100
-63.2%
0.22%
-68.8%
Q4 2014$3,202,000
+43.2%
179,675
-19.3%
0.72%
+32.4%
Q3 2014$2,236,000
-20.4%
222,725
+23.8%
0.54%
-10.2%
Q2 2014$2,808,000
+16.3%
179,900
+38.3%
0.60%
+6.1%
Q1 2014$2,415,000130,1000.57%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Engaged Capital LLC 3,487,149$21,376,0003.96%
Broadfin Capital, LLC 4,083,135$25,030,0003.29%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0001.30%
GENERAL AMERICAN INVESTORS CO INC 1,599,365$9,804,0001.03%
Grandeur Peak Global Advisors, LLC 821,038$5,033,0000.65%
CADENCE CAPITAL MANAGEMENT LLC 307,294$1,884,0000.19%
Redmond Asset Management, LLC 60,176$369,0000.18%
Alambic Investment Management, L.P. 65,000$398,0000.17%
MENTA CAPITAL LLC 39,562$243,0000.09%
Campbell & CO Investment Adviser LLC 12,990$88,0000.09%
View complete list of ARATANA THERAPEUTICS INC shareholders